2021 Insights into the In-vitro Diagnostics Global Market - Key Players Include Abbott Laboratories, Becton Dickinson and BioMerieux - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "In-vitro Diagnostics Global Market- Forecast to 2027" report has been added to ResearchAndMarkets.com's offering.

In-vitro diagnostic is a process in which reagents, instruments, and systems are intended for the diagnosis of disease or other conditions or for determining the state of health, to cure, mitigate, treat, or prevent disease. This includes reagents, calibrators, control materials, specimen receptacles, software, and related instruments.

The in-vitro diagnostics market is segmented into Enzyme-Linked Immunosorbent Assay (ELISA), Radioimmunoassay (RIA), Rapid tests, Enzyme-Linked Immunospot (Elispot) Assay and others are some of the immunoassay techniques in the IVD market. Basic Metabolic Panel, Electrolyte Panel, liver Panel, Lipid Profile, Renal Profile and Thyroid function panel and specialty chemical tests are some of the clinical chemistry technologies. Polymerase Chain Reaction (PCR), Isothermal Nucleic Acid Amplification Technology (INAAT), Microarray, Hybridization, DNA Sequencing & Next-Generation Sequencing and others are some of the molecular diagnostics market. Along with these, clinical microbiology, hematology, coagulation and hemostasis and others are the type of the IVD technologies in the market.

Among technologies in in-vitro diagnostics market, immunochemistry techniques accounted for the largest share in 2016 growing at mid range single digit CAGR and molecular diagnostics is expected to grow at high single digit CAGR from 2016-2023.

Growing healthcare expenditure in the emerging markets, strong demand for technologically advanced testing methods for disease diagnosis, increasing adaptation of point of care testing, increasing incidences of chronic lifestyle diseases are some of the important driving factors for this market. It is also seen that there is an increase in the number of clinical laboratories with improved infrastructure in many developed countries which could further push the diagnostics market in these regions. However, Lack of proper reimbursement policies in the developing countries and stringent regulatory framework are the main factors hampering the growth of the IVD market.

Market Dynamics

Drivers and Opportunities

• Growing Incidence of Chronic and Infectious Diseases
• Increase in Demand for IVD Tests Due to Covid-19 Pandemic
• Increasing Adoption of Point-Of-Care Testing
• The Emergence of Next-Generation Molecular Diagnostics
• Growing Awareness of Companion Diagnostics and Personalized Medicine
• The Emergence of Minimally Invasive and Non-Invasive Diagnostics
• Rising Number of Clia-Waived IVD Tests

Restraints & Threats

• Rising Incidence of Product Recalls
• Lack of Skilled Laboratory Technicians in Developing Nations
• Inadequate Reimbursement
• Stringent Regulatory Framework

Companies Mentioned

• Abacus Diagnostica
• Abbott Laboratories
• Abcodia
• Abionic Sa
• Accessdx
• Accuragen
• Accurex Biomedical
• Acrannolife Genomics
• Adaltis
• Adaptive Biotechnologies
• Admera Health
• Advanced Cell Diagnostics
• Aegea Biotechnologies
• Agappe Diagnostics
• Agilent
• Akonni Biosystems
• Altona Diagnostics
• Amoy Diagnostics
• Ams UK
• Andina Medica
• Applied Dna Sciences, Inc.
• Atlas Medical
• Axis-Shield Diagnostics Ltd.
• Axxin
• Babson Diagnostics
• BD
• Berry Genomics
• BGI
• Billiontoone
• Binx Health
• Bioazure Technologies
• Biocare Medical
• Biocat GmbH
• Biocept
• Biocientifica Sa
• Biodesix
• Bio-Genex Laboratories
• Biohelix
• Biomedica Diagnostics Inc.
• Biomerica
• Biomerirex
• Bioneer
• Bio-Rad
• Biotheranostics
• Biovica International Ab
• Bruker Corporation
• Cardiff Oncology
• Care Dx
• Carewell Biotech
• Centogene
• Certest Biotec Sl.
• Chembio Diagnostics
• Co-Diagnostics
• Color Health, Inc.
• Copan Diagnostics
• Creatv Microtech Inc.
• Credo Diagnostics
• Ctk Biotech
• Curetis
• Daan Gene
• Daiagnostic Biosystems
• Danaher
• Dcn Dx
• Delfi Diagnostics
• Dexcom
• Diabetomics Inc.
• Diacarta, Inc.
• Diagnosis
• Diasorin
• Diasource Immunoassays S.A.
• Drucker Diagnostics
• Ekf Diagnostics
• Elabscience
• Elitech Group
• Enterix, Inc
• Enzo Life Sciences
• Epigenomics
• Epitope Diagnostics
• Eppendorf AG
• Erba Mannheim
• Euromedix
• Exact Sciences
• Exosomics
• F. Hoffmann La Roche AG
• Firalis
• First Diagnostics Corporation
• Fosun Pharma
• Freenome
• Fusion Genomics
• Genefron
• Genekam Biotechnology AG
• Genetic Signatures
• Genomeme
• Genomica
• Genoptix
• Girfols
• Glysens, Inc
• Godx
• Gravity Diagnostics, LLC
• Gyros Protein Technologies
• Helena Laboratories
• Hologic(Mobidiag)
• Htg Molecular Diagnostics
• Hu Group(Fujirebio Diagnostics)
• Human Diagnostics
• Humor Diagnostica
• Hycel
• Hycor Biomedical
• Identa Ltd
• Igenomix
• Ilex South Africa
• Illumina
• Immucor Inc.
• Immudex
• Immuno Science (I) Pvt. Ltd
• Immunodiagnostic Systems
• Inbios
• Incelldx
• Indec Diagnostics
• Infinity Biologix LLC
• Inflammatix, Inc
• Inochem
• Insilixa,
• Interlabservice Ltd.
• Invivoscribe, Inc.
• J Mitro & Co. Pvt. Ltd.
• Jant Pharmacal Corporation.
• Kamineni Life Science
• Karius, Inc.
• Kephera Diagnostics
• Laboratorios Licon S.A.
• Laboratorios Rubio
• Lifescan
• Lightdeck Diagnostics
• Linear Chemicals S.L.U.
• Lucigen
• Luminex
• Luminous Biosciences,
• Lumos Diagnostics
• Mammoth Biosciences
• Mapmygenome India Ltd
• Mast Group
• Matmacorp
• Medica Corporation
• Medmira
• Medtronic
• And Many More Companies!

For more information about this report visit https://www.researchandmarkets.com/r/800fys